Replies to post #39774 on Ethema Health Corp (GRST)

[Niceguy1]

Been here six months and the co may be good but this ceo has lost 80% pps. I don't see that as particularly earth shattering performance

[Bubae]

Organic growth? LOL The only thing this CEO has grown to date is the toxic debt which is a documented fact in the filings. Ethema (GRST) has finally "bought" into a business entity that they have moved around several times posting huge losses. The real "investors" own much of the assets, that they have financed with the toxic notes, in the form of preferred shares and options.

Ethema (GRST) is a self described "investment holding" company with 2 employees who serve the actual "investors". Traders of this stock pay for the debt and expenses. The best a trader can do here, as with nearly all OTC tickers, is try to pick a position from which to flip. When that fails they become a contributor to what really has been a disaster for shareholders. They aren't done with this group of trades yet, LABRYS fund will at least get the $550K note converted in my opinion. That will be around $1.1 million in shares or nearly 1.4 billion new shares.

They are still borrowing to operate. They are servicing over $18 million in current liabilities with $119K in quarterly net earnings? The best that can be said is that is is better than last quarter but it sure as h#ll better be with $509.5 million new shares for Q3. According to the statement they will need an additional $1.5 million in working capital. Notice how they refer to it as Evernia again. This entity is referred to as Evernia, ARIA, and ATHI for reasons that I can only assume is to create confusion when reading the filing. They have done this over and over in the past.

Q3 2021 10Q filing
https://sec.report/Document/0001721868-21-000835/

Liquidity and Capital Resources

..."Over the next twelve months we estimate that the company will require approximately $1.5 million in working capital as it continues to develop the Evernia facility and it is also exploring several other treatment center options and sources of patients throughout the country. The company may have to raise equity or secure debt. There is no assurance that the Company will be successful with future financing ventures, and the inability to secure such financing may have a material adverse effect on the Company’s financial condition. In the opinion of management, the Company’s liquidity risk is assessed as medium."...